Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2019-11-01 Earnings Release
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA: Resultat for tredje kvartal 2019
Earnings Release Classification · 98% confidence The document is titled "Navamedic ASA: Resultat for tredje kvartal 2019" (Result for the third quarter 2019) and contains key financial metrics (operating income, EBITDA) for that specific period, comparing them to the previous year. This content structure is characteristic of an initial announcement of periodic financial results, focusing on highlights rather than the comprehensive detail found in a full quarterly report (IR). Therefore, it aligns best with the Earnings Release (ER) definition. Q3 2019
2019-11-01 Norwegian
Completion of the demerger of Navamedic ASA; registration of changes in the share capital of Navamedic ASA and amendment of articles of association of Navamedic ASA
Share Issue/Capital Change Classification · 98% confidence The document explicitly details the 'Completion of the demerger of Navamedic ASA' and the resulting 'registration of changes in the share capital of Navamedic ASA and amendment of articles of association'. Key elements include changes to share capital (reduction, nominal value change), issuance of consideration shares in the spun-off entity (Observe Medical ASA), setting of cut-off and record dates, and the commencement of trading for the new entity. These actions directly relate to changes in the company's capital structure and share issuance/distribution following a corporate action (demerger). This aligns best with the 'Share Issue/Capital Change' definition (SHA), as the core event is the restructuring of shares and capital between two entities.
2019-10-31 English
Completion of the demerger of Navamedic ASA; registration of changes in the share capital of Navamedic ASA and amendment of articles of association of Navamedic ASA
Share Issue/Capital Change Classification · 99% confidence The document explicitly details the 'Completion of the demerger of Navamedic ASA' involving changes to the share capital, nominal value of shares, and the issuance of consideration shares in the spun-off entity, Observe Medical ASA. This involves significant structural changes to the company's capital base and ownership structure due to a corporate action (demerger). This fits the definition of a Capital/Financing Update (CAP), as it concerns changes in capital structure and fundraising/restructuring activities, rather than a standard earnings report (ER/IR) or a simple announcement of a report (RPA). The document is detailed enough to be the primary disclosure of the event, not just a notice of publication.
2019-10-31 English
Navamedic ASA shares: Last day of trading inclusive of rights to consideration shares in Observe Medical ASA
M&A Activity Classification · 95% confidence The document announces specific corporate actions related to a demerger (spin-off) involving Navamedic ASA and Observe Medical ASA. Key events mentioned are the last day of trading inclusive of rights, the completion of the demerger registration, the record date for share distribution, and the commencement of trading for the new entity (Observe Medical). This content describes a significant change in the company's capital structure and ownership rights resulting from a corporate reorganization, which aligns best with the 'Capital/Financing Update' category, as it details the mechanics of distributing shares from a demerged entity to existing shareholders. It is not a standard earnings release, annual report, or management discussion. While it involves share distribution, it is more comprehensive than a simple 'Share Issue' (SHA) as it details the entire demerger process outcome.
2019-10-31 English
Navamedic ASA shares: Last day of trading inclusive of rights to consideration shares in Observe Medical ASA
Delisting Announcement Classification · 99% confidence The document is a short announcement from Navamedic ASA dated October 31, 2019, detailing the final trading day for its shares inclusive of rights to consideration shares in Observe Medical ASA due to a demerger. This announcement concerns a corporate action involving the exchange of shares and capital structure change related to the demerger. It is not a full annual report (10-K), an earnings release (ER), or a standard quarterly report (IR). It specifically details the mechanics of a corporate transaction involving share distribution and trading cessation/commencement. This fits best under Capital/Financing Update (CAP) as it directly relates to a change in capital structure resulting from the demerger and subsequent share distribution, or potentially Regulatory Filings (RNS) if it's a mandatory disclosure that doesn't fit other specific categories. Given the focus on the mechanics of share distribution and trading related to a demerger, 'Capital/Financing Update' (CAP) is the most appropriate specific category, as it describes a significant capital restructuring event. Since the document length is short (3658 chars) and it is a direct announcement of a corporate event rather than a detailed report, CAP is preferred over RNS if the event is fundamentally about capital structure.
2019-10-31 English
Navamedic ASA - Oslo Børs approves listing of Observe Medical ASA on Oslo Axess
Share Issue/Capital Change Classification · 95% confidence The document announces the approval of the listing of Observe Medical ASA on Oslo Axess following a demerger from Navamedic ASA. It details key dates related to the completion of the demerger, the exchange of shares, and the commencement of trading for the new entity. This content describes a significant corporate action involving capital structure change (demerger and subsequent listing/share issuance) and is not a standard periodic report (10-K, IR, ER) or a general regulatory filing (RNS). It most closely aligns with an announcement regarding a change in capital structure or a significant transaction, fitting best under 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if CAP is too narrow. Given the focus on the mechanics of the share exchange and listing resulting from the demerger, CAP is the most specific fit, as it involves a fundamental change to the company's capital structure and financing mechanism (listing). Since it is a specific announcement about a corporate transaction affecting shares and capital, CAP is preferred over the general RNS.
2019-10-30 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.